Motivation and Barriers for Exercise in Patients With Anxiety or Posttraumatic Stress Disorder

March 25, 2020 updated by: Universitaet Innsbruck

Relevance and Aim: There has been increasing research interest in sport preferences and motivational factors as well as barriers that restrain from engaging in sport activities in people suffering from mental illnesses. Anxiety disorders are one of the leading mental disorders worldwide. Exercise has previously shown anxiolytic effects and is discussed as an adjunctive treatment option in clinical practice. This study aims to depict motivation and barriers in patients with anxiety or posttraumatic stress disorders.

Design and Participants: Observational study of patients diagnosed with anxiety disorder or posttraumatic stress disorder (ICD-10)

Measurements: Structured questionnaire compounded of validated scales for current physical activity, sport motivation, exercise preferences, perceived barriers , self-efficacy, social support for physical activity, motivation,enjoyment, quality of life as well as sociodemographic data.

Duration: The questionnaire will require approximately 20 minutes, the overall duration is 3 months. Personal assistance for completing the questionnaire will be provided if necessary.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

460

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tyrol
      • Innsbruck, Tyrol, Austria, 6020
        • University of Innsbruck

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients of outpatient department and inpatients of the Medical Hospital Innsbruck, Department of Psychiatry and Psychosomatic will be selected by clinical professionals according to inclusion and exclusion criteria.

Description

Inclusion Criteria:

  • In- and out-patients with a diagnosed anxiety or posttraumatic stress disorder (F40, F41, F43.1; ICD-10)
  • 18 to 65 years

Exclusion Criteria:

  • acute psychosis or suicidal behaviour
  • cognitive deficits
  • problems with German language

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Clinical Population
In- and Out-Patients diagnosed with depression (F32, F33), anxiety disorder (F40, F41; ICD-10) or posttraumatic stress disorder (F43.1; ICD-10)
Healthy Controls
Subjects with no previous or actual mental disorder

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical activity
Time Frame: 5 minutes
self reported, actual physical activity, measured by the International Physical Activity Questionnaire Short Form, IPAQ-SF; Craig et al., 2003
5 minutes
Sport motivation
Time Frame: 5 minutes
measured by the Exercise Motivation Inventory, EMI-2; Markland & Hardy,1993
5 minutes
Perceived barriers
Time Frame: 5 minutes
measured by 12 questions referring to Ussher, Stanbury, Cheeseman & Faulkner, 2007
5 minutes
Self-efficacy for physical activity
Time Frame: 1 minute
single item question according to Ussher, Stanbury, Cheeseman & Faulkner, 2007
1 minute
Social support for physical activity
Time Frame: 1 minute
single item question according to Ussher, Stanbury, Cheeseman & Faulkner, 2007
1 minute
Motivation for physical activity
Time Frame: 1 minute
single item question according to Ussher, Stanbury, Cheeseman & Faulkner, 2007
1 minute
Enjoyment of physical activity
Time Frame: 1 minute
single item question according to Ussher, Stanbury, Cheeseman & Faulkner, 2007
1 minute

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Martin Kopp, PhD, Prof., Department of Sport Science, University of Innsbruck
  • Study Director: Barbara Sperner-Unterweger, MD, Prof., Department of Psychosomatics, Medical University of Innsbruck

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 7, 2019

Primary Completion (Actual)

October 1, 2019

Study Completion (Actual)

December 30, 2019

Study Registration Dates

First Submitted

January 24, 2019

First Submitted That Met QC Criteria

January 24, 2019

First Posted (Actual)

January 28, 2019

Study Record Updates

Last Update Posted (Actual)

March 27, 2020

Last Update Submitted That Met QC Criteria

March 25, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise

3
Subscribe